Insulin Signaling in Type 2 Diabetes

Background: Mechanisms of insulin resistance in type 2 diabetes are not known. Results: A first dynamic mathematical model based on data from human adipocytes yields systems level understanding of insulin resistance. Conclusion: Attenuation of an mTORC1-derived feedback in diabetes explains reduced sensitivity and signal strength throughout the insulin-signaling network. Significance: Findings give a molecular basis for insulin resistance in the signaling network. Type 2 diabetes originates in an expanding adipose tissue that for unknown reasons becomes insulin resistant. Insulin resistance reflects impairments in insulin signaling, but mechanisms involved are unclear because current research is fragmented. We report a systems level mechanistic understanding of insulin resistance, using systems wide and internally consistent data from human adipocytes. Based on quantitative steady-state and dynamic time course data on signaling intermediaries, normally and in diabetes, we developed a dynamic mathematical model of insulin signaling. The model structure and parameters are identical in the normal and diabetic states of the model, except for three parameters that change in diabetes: (i) reduced concentration of insulin receptor, (ii) reduced concentration of insulin-regulated glucose transporter GLUT4, and (iii) changed feedback from mammalian target of rapamycin in complex with raptor (mTORC1). Modeling reveals that at the core of insulin resistance in human adipocytes is attenuation of a positive feedback from mTORC1 to the insulin receptor substrate-1, which explains reduced sensitivity and signal strength throughout the signaling network. Model simulations with inhibition of mTORC1 are comparable with experimental data on inhibition of mTORC1 using rapamycin in human adipocytes. We demonstrate the potential of the model for identification of drug targets, e.g. increasing the feedback restores insulin signaling, both at the cellular level and, using a multilevel model, at the whole body level. Our findings suggest that insulin resistance in an expanded adipose tissue results from cell growth restriction to prevent cell necrosis.

[1]  V. Kiselyov,et al.  Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation , 2009, Molecular systems biology.

[2]  I. Gout,et al.  The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.

[3]  G. Thomas,et al.  ReviewNutrient overload , insulin resistance , and ribosomal protein S 6 kinase 1 , S 6 K 1 , 2022 .

[4]  P. Strålfors,et al.  Attenuated mTOR Signaling and Enhanced Autophagy in Adipocytes from Obese Patients with Type 2 Diabetes , 2010, Molecular medicine.

[5]  Gunnar Cedersund,et al.  A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis* , 2011, The Journal of Biological Chemistry.

[6]  M. White,et al.  Irs1 serine 307 promotes insulin sensitivity in mice. , 2010, Cell metabolism.

[7]  Claudio R. Santos,et al.  SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.

[8]  F. Liu,et al.  Autophagy-Mediated Insulin Receptor Down-Regulation Contributes to Endoplasmic Reticulum Stress-Induced Insulin Resistance , 2009, Molecular Pharmacology.

[9]  M. White,et al.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.

[10]  P. Strålfors,et al.  Short-Term Overeating Induces Insulin Resistance in Fat Cells in Lean Human Subjects , 2009, Molecular medicine.

[11]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[12]  P. Strålfors,et al.  Retinol‐binding protein‐4 attenuates insulin‐induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Shoelson,et al.  Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302* , 2004, Journal of Biological Chemistry.

[14]  L. Schaeffer,et al.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy , 2009, The Journal of cell biology.

[15]  H. Tanak,et al.  Density functional computational studies on (E)-2-[(2-Hydroxy-5-nitrophenyl)-iminiomethyl]-4-nitrophenolate , 2010, Journal of molecular modeling.

[16]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[17]  P. Strålfors,et al.  Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes* , 2005, Journal of Biological Chemistry.

[18]  Gunnar Cedersund,et al.  Conclusions via unique predictions obtained despite unidentifiability – new definitions and a general method , 2012, The FEBS journal.

[19]  Maria J. Pereira,et al.  mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes , 2012, Molecular and Cellular Endocrinology.

[20]  A. Sonntag,et al.  A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation , 2012, Science Signaling.

[21]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[22]  P. Strålfors,et al.  Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. , 1989, European journal of biochemistry.

[23]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[24]  J. Auwerx,et al.  Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.

[25]  A. Jeukendrup,et al.  Exercise training increases adipose tissue GLUT4 expression in patients with type 2 diabetes , 2011, Diabetes, obesity & metabolism.

[26]  M. Hur,et al.  Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. , 2006, The Biochemical journal.

[27]  D. Sabatini,et al.  The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.

[28]  John C. Lawrence,et al.  Muscle-Specific Deletion of Rictor Impairs Insulin-Stimulated Glucose Transport and Enhances Basal Glycogen Synthase Activity , 2007, Molecular and Cellular Biology.

[29]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[30]  G. Cedersund,et al.  Insulin signaling – mathematical modeling comes of age , 2012, Trends in Endocrinology & Metabolism.

[31]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[32]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[33]  L. Groop,et al.  Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Wei Chen,et al.  Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. , 2001, Diabetes.

[35]  L. Lissner,et al.  Adipocyte size predicts incidence of type 2 diabetes in women , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. Olefsky.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. , 1976, The Journal of clinical investigation.

[37]  E. Van Obberghen,et al.  [Mechanisms of insulin resistance]. , 1989, Journees annuelles de diabetologie de l'Hotel-Dieu.

[38]  Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking. , 2001, The Journal of clinical endocrinology and metabolism.

[39]  P. Strålfors,et al.  Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual , 2007, Diabetologia.

[40]  M. Lane,et al.  Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes. , 1987, The Journal of biological chemistry.

[41]  Gunnar Cedersund,et al.  Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework* , 2010, The Journal of Biological Chemistry.

[42]  M. White,et al.  Nutrient-dependent and Insulin-stimulated Phosphorylation of Insulin Receptor Substrate-1 on Serine 302 Correlates with Increased Insulin Signaling* , 2004, Journal of Biological Chemistry.

[43]  N. Møller,et al.  GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance , 2011, PloS one.

[44]  Anne E Carpenter,et al.  mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.

[45]  E. Schleicher,et al.  Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells. , 2008, Molecular endocrinology.

[46]  Ursula Klingmüller,et al.  Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood , 2009, Bioinform..

[47]  P. Arner,et al.  Regulation of lipolysis in small and large fat cells of the same subject. , 2011, The Journal of clinical endocrinology and metabolism.

[48]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[49]  G. Thomas,et al.  Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.

[50]  Peter Strålfors,et al.  Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes , 2004, The FEBS journal.